Gesundheitswesen

36

SPEZIALISIERTE PROFESSIONALS

282

ABGESCHLOSSENE TRANSAKTIONEN

52

AKTUELLE MANDATE

Die Spezialisten von Oaklins verstehen auf globaler und lokaler Ebene die aufsichtsrechtlichen Gegebenheiten, aktuelle Erstattungssysteme, die technologischen und medizinischen Versorgungsstandards und die Situation der Patienten. Wir kennen die wichtigsten Akteure und können jede M&A-Transaktion aus globaler Perspektive begutachten. Wir suchen für unsere Kunden die richtigen strategischen Partner, maximieren das Synergiepotenzial und realisieren hervorragende Bewertungen. So arbeiten wir bei Oaklins.

LETZTE TRANSAKTIONEN
GESUNDHEITSWESEN

Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image

BRANCHENKEYKONTAKT

Dr. Hans Bethge

Deutschland

Vorstand

KURZPROFIL

Christian Jellentrup

Deutschland

Senior Associate

KURZPROFIL

AKTUELLE NEWS

Oaklins’ team in Russia will join SFM Group at the BIO 2017

9 Mai 2017
Our client, SFM Group, is going to attend the world’s largest global biotechnology event BIO 2017 International Convention taking place from 19–22 June 2017 in San Diego, USA. SFM Group, is an innovative Russian pharmaceutical company specializing in pharma R&D and has its own production facilities. Its product portfolio includes medicines to treat cardio-vascular diseases, viral infections, regenerative medicines, etc. Its breakthrough product is Trombovazim, a powerful thrombolytic…

LESEN SIE MEHR

Globalizing cutting edge technology in point-of-care patient blood management

30 November 2016
DEAL FLASH: Oaklins’ team in Switzerland advised the shareholders of TEM Group on the sale of the company to Instrumentation Laboratory (IL). The team acted as lead advisor to the shareholders of TEM Group throughout the sale process. This deal demonstrates the value and competitive advantage Oaklins provides in guiding the client in a very close personal relationship through all stages of the process. Read…

LESEN SIE MEHR

Shareholder succession at Sphinx Werkzeuge AG

29 September 2016
The owners of Sphinx Werkzeuge AG have sold a majority stake in the company to Helvetica Capital AG and members of the management team. Financial details were not disclosed. Sphinx Werkzeuge is a leading precision tools developer and manufacturer for high precision mechanical and medical applications. The company’s core business is the production of micro to small drills. In the medical technology industry, its products…

LESEN SIE MEHR

Instrumentation Laboratory Acquires CA CASYSO AG, Including TEM® subsidiaries and ROTEM® Testing Systems

26 September 2016
Instrumentation Laboratory (IL) acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a global leader in in vitro diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. Tem is a global leader in in-vitro-diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. With a direct sales force in seven markets, including the US,…

LESEN SIE MEHR

A new rehabilitation pathway for acquired brain injuries

29 April 2016
DEAL FLASH:  Smith & Williamson advised the shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) on the sale of the company to CareTech Holdings Plc (CareTech). Oakleaf provides brain injury rehabilitation to adult males requiring specialist care and long-term support. The in-depth healthcare sector knowledge and experience of our team of advisors was crucial to achieving a successful sale. Read more about the transaction, market trends,…

LESEN SIE MEHR

Cross-border deal in biosimilars

26 November 2015
HEALTHCARE DEAL FLASH:  Oaklins’ Swedish and Italian teams advised the shareholders of Xbrane Biosciences AB (Xbrane) on the acquisition of Primm Pharma. They supported the buyer by scouting the Italian market, identifying the most suitable target, and assisting in the LOI formulation and in negotiations throughout the process. Through the acquisition, Xbrane will be able to broaden their expertise within the field of high demand…

LESEN SIE MEHR

Consolidation continues in the dental industry

16 Oktober 2015
HEALTHCARE DEAL FLASH:  Our Oaklins’ team in the Netherlands and Cavendish, an Oaklins member firm in the UK, advised the shareholders of C.D.C. Complete tandzorg (CDC) in the sale of a stake in the company to G Square Healthcare Private Equity. The partnership will enable CDC to expand its dental care services to other regions in the Netherlands by opening new dental practices. Read more…

LESEN SIE MEHR